CHIRON CAPITAL MANAGEMENT, LLC

Position in TGTX — Tg Therapeutics, Inc.

CIK 1830922 TALLAHASSEE, FL

Position in TGTX

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$208,772

-$27,208 QoQ

Shares Held

3,800

-60.0% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.21%

of 13F equity value

Holder Rank

#317

of 425 holders

Holding Since

Sep 2020

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CHIRON CAPITAL MANAGEMENT, LLC holds $1,195,948 across 5 Biotechnology names. TGTX ranks #4 (17.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BMRN	Biomarin Pharmaceutical Inc	5,850	$334,737
2	DFTX	Definium Therapeutics, Inc.	7,000	$329,280
3	ATAI	AtaiBeckley Inc.	50,126	$264,164
4	TGTX	Tg Therapeutics, Inc. This page	3,800	$208,772
5	PGEN	Precigen, Inc.	10,350	$58,995

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$208,772	3,800	-60.0%	Shares	Sole	2026-07-21
2023-06-30	$235,980	9,500	-21.5%	Shares	Sole	2023-07-27
2023-03-31	$181,984	12,100	+14.0%	Shares	Sole	2023-04-21
2022-12-31	$125,599	10,617	-0.9%	Shares	Sole	2023-01-23
2022-06-30	$45,547	10,717	-21.7%	Shares	Sole	2022-07-25
2022-03-31	$130,210	13,692	+16.3%	Shares	Sole	2022-04-18
2021-12-31	$223,668	11,772	+166.0%	Shares	Sole	2022-01-18
2020-09-30	$118,413	4,425	—	Shares	Sole	2020-11-19
No filing history on record for this holder in this stock.